Higgins; Mendi A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Higgins; Mendi A..The latest application filed is for "indazole derivatives as alpha v integrin antagonists".

Company Profile

2.8.7

Higgins; Mendi A. - Newtown PA
Higgins; Mendi A. - Meriden CT
Higgins; Mendi A. - Middletown CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Indazole derivatives as alpha v integrin antagonists Grant 11,028,071 - Ye , et al. June 8, 2	2021-06-08
Indazole Derivatives As Alpha V Integrin Antagonists App 20200339540 - Ye; Xiang-Yang ; et al.	2020-10-29
Indazole derivatives as .alpha.v integrin antagonists Grant 10,745,384 - Ye , et al. A	2020-08-18
Triazolopyridine ether derivatives and their use in neurological and pyschiatric disorders Grant 9,738,642 - Marcin , et al. August 22, 2	2017-08-22
Triazolopyridine Ether Derivatives And Their Use In Neurological And Pyschiatric Disorders App 20160237081 - Marcin; Lawrence R. ; et al.	2016-08-18
Compounds for the reduction of beta-amyloid production Grant 8,604,024 - Thompson, III , et al. December 10, 2	2013-12-10
Compounds For The Reduction Of Beta-amyloid Production App 20130131051 - THOMPSON, III; LORIN A. ; et al.	2013-05-23
Bicyclic compounds for the reduction of beta-amyloid production Grant 8,349,880 - Marcin , et al. January 8, 2	2013-01-08
Bicyclic Compounds for the Reduction of Beta-Amyloid Production App 20110015175 - Marcin; Lawrence R. ; et al.	2011-01-20
Antiamyloid phenylsulfonamides: N-cycloalkylcarboxamides derivatives Grant 7,084,178 - Marcin , et al. August 1, 2	2006-08-01
Antiamyloid phenylsulfonamides: N-cycloalkylcarboxamides derivatives App 20050113442 - Marcin, Lawrence R. ; et al.	2005-05-26
Cyclopropylindole derivatives as selective serotonin reuptake inhibitors Grant 6,777,437 - Mattson , et al. August 17, 2	2004-08-17
Cyclopropylindole derivatives as selective serotonin reuptake inhibitors App 20030073849 - Mattson, Ronald J. ; et al.	2003-04-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.